GLP-1 Weight Loss Review
AbundRx Reviews 2026: Semaglutide and Tirzepatide GLP-1 From $99/mo
AbundRx runs a two-program GLP-1 lineup, compounded semaglutide starting at $99/month and compounded tirzepatide starting at $149/month, screened through a short online quiz and a licensed-clinician review rather than an in-person visit.
- LegitScript Certified
- U.S.-licensed clinicians
- No insurance required
- Free shipping, ships in 2 days
No obligation to purchase — a licensed clinician determines eligibility after the quiz
By Charly P. · Published August 31, 2026 · 10 min read
- LegitScript Certified
- HIPAA-compliant platform
- 100% online intake
- Cancel anytime
AbundRx prices semaglutide at $99/month and tirzepatide at $149/month, undercutting several mid-tier telehealth GLP-1 platforms, though not the cheapest in the category. A short quiz feeds a licensed-clinician review before any medication is prescribed, backed by a LegitScript certification.
About AbundRx: What Makes It Different
AbundRx (operated by Abundant Wellness, West Palm Beach, FL) is a telehealth weight-loss brand built around two compounded GLP-1 medications — semaglutide and tirzepatide — dispensed after a U.S.-licensed clinician reviews a short online intake.
| Operator | Abundant Wellness, West Palm Beach, FL |
|---|---|
| Patients served | 100,000+ (company-stated) |
| Certification | LegitScript Certified — third-party pharmacy/telehealth compliance review |
| Intake | ~2-minute quiz, non-binding, no obligation to purchase |
| Eligibility review | U.S.-licensed clinician |
| If approved | Personalized plan, medication shipped free within 2 days |
| Cancellation | Can stop the process at any point before checkout |
How We Scored AbundRx
How We Scored It
$99/mo semaglutide and $149/mo tirzepatide undercut most brand-name and several compounded competitors, though not the single cheapest tier in the category.
LegitScript Certified with a published business address and support line — solid but not independently verified by us beyond the certification itself.
Two-format lineup (semaglutide and tirzepatide), U.S.-licensed clinician review, free shipping within two days.
The site's headline results (18% average weight loss, etc.) are brand-reported, not independently verified clinical outcomes.
100% online quiz-based intake, no insurance required, described as cancel-anytime.
Scores reflect our editorial assessment of AbundRx's published program as of August 2026, not a clinical rating.
AbundRx Pricing 2026
AbundRx prices its two GLP-1 programs separately, both advertised as all-in starting rates that include the clinician review and shipping.
AbundRx pricing by program
| Program | Starting Price | Dosing |
|---|---|---|
| Semaglutide (GLP-1 injections) | $99/month | Weekly |
| Tirzepatide (GLP-1/GIP injections) | $149/month | Weekly |
How that compares
| Provider | Semaglutide From | Tirzepatide From |
|---|---|---|
| AbundRx | $99/mo | $149/mo |
| altRx | $89/mo | $149/mo |
| TrimRx | $149/mo | $249/mo |
| BetterMe Rx | $155/mo | $225/mo |
Against altRx, AbundRx's semaglutide entry price is $10 higher per month, but the two are tied on tirzepatide at $149/month. Against TrimRx, AbundRx undercuts both programs by $50–$100 a month. Read as a set, AbundRx sits toward the lower end of the compounded-GLP-1 pricing band without claiming to be the single cheapest option we've reviewed.
How AbundRx Works
- 1.Answer a few questions
Complete a roughly two-minute intake covering basic health details. AbundRx states this step is private, secure, and not a commitment to purchase.
- 2.Clinician review
A U.S.-licensed provider reviews your submission and determines eligibility for either the semaglutide or tirzepatide program.
- 3.Personalized plan and delivery
If appropriate, you receive guidance on a personalized dosing plan, with medication shipped free within two days.
- 4.Ongoing support
AbundRx describes the program as HIPAA-compliant with the ability to cancel at any point, rather than a fixed-term contract.
AbundRx's Reported Results
AbundRx publishes a set of program-wide statistics on its site:
| Average weight loss | 18% (brand-reported) |
|---|---|
| Patient effectiveness rating | 9/10 (brand-reported) |
| Average waist reduction | 6.5 in (brand-reported) |
| Patients maintaining weight loss | 93% (brand-reported) |
| Testimonial range | Named patients reporting ~29–42 lb losses |
Pros and Cons
Pros
- Semaglutide starts at $99/mo, tirzepatide at $149/mo — undercuts several mid-tier compounded competitors
- Two-program lineup gives a choice between semaglutide and dual-action tirzepatide
- LegitScript Certified, with a published business address and support contact
- Free shipping advertised within two days of approval
- No insurance required, HIPAA-compliant intake, and described as cancel-anytime
- Short, low-friction quiz-based intake with a licensed-clinician eligibility review
Cons
- Headline results (18% average weight loss, 93% maintenance, etc.) are brand-reported, not independently verified
- Dispenses compounded medication, not an FDA-approved brand-name product
- Starting prices are advertised rates; confirm the total cost as your dose escalates
- No published multi-month price-lock or membership-fee structure comparable to some competitors
Who AbundRx Is For
Good fit if you...
- ✓Want a lower-cost entry into compounded GLP-1 therapy
- ✓Want a choice between semaglutide and dual-action tirzepatide
- ✓Prefer a short, quiz-based intake over scheduling an in-person visit
- ✓Value a LegitScript certification and published contact details when vetting a newer telehealth brand
Weaker fit if you...
- Want an FDA-approved brand-name medication rather than a compounded preparation
- Want the absolute lowest advertised price — altRx edges AbundRx out on semaglutide
- Would treat the reported-results numbers as a substitute for discussing realistic expectations with your prescribing clinician
AbundRx Alternatives
Looking for alternatives to AbundRx? Here are the top-rated GLP-1 weight loss programs we recommend:
- altRx: semaglutide $10/month lower, matches AbundRx exactly on tirzepatide at $149/month — best if price is your main driver.
- TrimRx: centers its pitch on a Lifetime Price Lock rather than the lowest starting number — better if a locked-in rate as you titrate matters more than entry price.
- BetterMe Rx: offers both injectable and oral tablet formats, which AbundRx does not.
Recommended Providers
Our editorial team’s top picks for this category.
Frequently Asked Questions
Bottom Line
Our Editorial Take
AbundRx does the basics of this category well: two clearly priced GLP-1 programs, a short intake that doesn't pretend to be more binding than it is, a real clinician review before anything ships, and a LegitScript certification that gives a newer brand something more concrete to point to than a landing page. At $99/month for semaglutide and $149/month for tirzepatide, it prices competitively against the mid-tier of the category without positioning itself as the absolute cheapest option.
Where I'd slow down is the results section. The 18% average weight loss and 93% maintenance figures are the kind of numbers that shape a purchase decision, and AbundRx presents them without an independent source behind them. That doesn't make them false, but it means they should inform your expectations the same way any marketing claim does, not the way a published clinical trial result would. Overall: 8.6/10.
Caveat: compounded GLP-1 pricing and availability change frequently. Confirm your current rate and program details directly with AbundRx before committing.
Safety and Regulatory Context
According to the FDA, semaglutide and tirzepatide are approved for chronic weight management under specific clinical criteria, and the agency has published guidance distinguishing compounded preparations, like the ones AbundRx dispenses, from FDA-approved finished products.
The CDC reports that roughly 40% of U.S. adults have obesity, which is the demand backdrop against which brands like AbundRx have expanded so quickly, and against which self-reported program statistics should be weighed carefully rather than taken as clinical evidence.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.